Skip to main content
Erschienen in: Endocrine 2/2018

20.08.2018 | Meta-Analysis

The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis

verfasst von: Xiaoling Cai, Yifei Chen, Wenjia Yang, Xueying Gao, Xueyao Han, Linong Ji

Erschienen in: Endocrine | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To clarify the relevance between smoking and diabetic retinopathy in patients with type 1 and type 2 diabetes mellitus.

Methods

Published evidence were searched in MEDLINE and EMBASE from the databases began until Feb. 2017. Studies evaluating the association between smoking and diabetic retinopathy or evaluating the risk factors of diabetic retinopathy including smoking were included.

Results

Totally 73 studies were identified, among which 19 studies included type 1 diabetes patients and 56 studies included type 2 diabetes patients. In type 1 diabetes, compare with non-smokers, the risk of diabetic retinopathy significantly increased in smokers (risk ratio (RR) = 1.23, 95% CI 1.14, 1.33, P < 0.001), and the risk of proliferative diabetic retinopathy also significantly increased in smokers (RR = 1.48, 95% CI 1.20, 1.81, P < 0.001). In type 2 diabetes, compare with non-smokers, the risk of diabetic retinopathy significantly decreased in smokers (RR = 0.92, 95% CI 0.86, 0.98, P = 0.02) and the risk of proliferative diabetic retinopathy also significantly decreased in smokers (RR = 0.68, 95% CI 0.61, 0.74, P < 0.001).

Conclusions

Compare with non-smokers, the risk of diabetic retinopathy significantly increased in smokers with type 1 diabetes while significantly decreased in smokers with type 2 diabetes. However, this result did not change the importance of smoking cessation for public health.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat American Diabetes, A., Microvascular complications and foot care: standards of medical care in diabetes-2018. Diabetes Care 41(Suppl 1), S105–S118 (2018). American Diabetes, A., Microvascular complications and foot care: standards of medical care in diabetes-2018. Diabetes Care 41(Suppl 1), S105–S118 (2018).
2.
Zurück zum Zitat R. Klein, Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18(2), 258–268 (1995)CrossRef R. Klein, Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18(2), 258–268 (1995)CrossRef
3.
Zurück zum Zitat R.O. Estacio, E. McFarling, S. Biggerstaff, B.W. Jeffers, D. Johnson, R.W. Schrier, Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am. J. Kidney Dis. 31(6), 947–953 (1998)CrossRef R.O. Estacio, E. McFarling, S. Biggerstaff, B.W. Jeffers, D. Johnson, R.W. Schrier, Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am. J. Kidney Dis. 31(6), 947–953 (1998)CrossRef
4.
Zurück zum Zitat M.C. Leske, S.Y. Wu, A. Hennis, Hyman. B, Nemesure. L, Yang. A.P, Schachat; Barbados Eye Study, G., Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies. Ophthalmology 112(5), 799–805 (2005).CrossRef M.C. Leske, S.Y. Wu, A. Hennis, Hyman. B, Nemesure. L, Yang. A.P, Schachat; Barbados Eye Study, G., Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies. Ophthalmology 112(5), 799–805 (2005).CrossRef
5.
Zurück zum Zitat E.Y. Chew, M.D. Davis, R.P. Danis, J.F. Lovato, L.H. Perdue, C. Greven, S. Genuth, D.C. Goff, L.A. Leiter, F. Ismail-Beigi, W.T. Ambrosius, Action to Control Cardiovascular Risk in Diabetes Eye Study Research, G., The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology 121(12), 2443–2451 (2014).CrossRef E.Y. Chew, M.D. Davis, R.P. Danis, J.F. Lovato, L.H. Perdue, C. Greven, S. Genuth, D.C. Goff, L.A. Leiter, F. Ismail-Beigi, W.T. Ambrosius, Action to Control Cardiovascular Risk in Diabetes Eye Study Research, G., The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study. Ophthalmology 121(12), 2443–2451 (2014).CrossRef
6.
Zurück zum Zitat I.M. Stratton, E.M. Kohner, S.J. Aldington, R.C. Turner, R.R. Holman, S.E. Manley, D.R. Matthews, UKPDS 50:risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44(2), 156–163 (2001).CrossRef I.M. Stratton, E.M. Kohner, S.J. Aldington, R.C. Turner, R.R. Holman, S.E. Manley, D.R. Matthews, UKPDS 50:risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44(2), 156–163 (2001).CrossRef
7.
Zurück zum Zitat W. Zhu, Y.F. Meng, Y. Wu, M. Xu, J. Lu, Association of alcohol intake with risk of diabetic retinopathy: a metaanalysis of observational studies. Sci. Rep 7(1), 4 (2017).CrossRef W. Zhu, Y.F. Meng, Y. Wu, M. Xu, J. Lu, Association of alcohol intake with risk of diabetic retinopathy: a metaanalysis of observational studies. Sci. Rep 7(1), 4 (2017).CrossRef
8.
Zurück zum Zitat F. Costa, R. Soares, Nicotine: a pro-angiogenic factor. Life Sci 84(23-24), 785–790 (2009).CrossRef F. Costa, R. Soares, Nicotine: a pro-angiogenic factor. Life Sci 84(23-24), 785–790 (2009).CrossRef
9.
Zurück zum Zitat P.B. Morgado, H.C. Chen, V. Patel, L. Herbert, E.M. Kohner, The acute effect of smoking on retinal blood flow in subjects with and without diabetes. Ophthalmology 101(7), 1220–1226 (1994)CrossRef P.B. Morgado, H.C. Chen, V. Patel, L. Herbert, E.M. Kohner, The acute effect of smoking on retinal blood flow in subjects with and without diabetes. Ophthalmology 101(7), 1220–1226 (1994)CrossRef
10.
Zurück zum Zitat I.D. Nicholl, R. Bucala, Advanced glycation endproducts and cigarette smoking. Cell Mol. Biol. 44(7), 1025–1033 (1998)PubMed I.D. Nicholl, R. Bucala, Advanced glycation endproducts and cigarette smoking. Cell Mol. Biol. 44(7), 1025–1033 (1998)PubMed
11.
Zurück zum Zitat M.E. Paetkau, T.A. Boyd, B. Winship, M. Grace, Cigarette smoking and diabetic retinopathy. Diabetes 26(1), 46–49 (1977)CrossRef M.E. Paetkau, T.A. Boyd, B. Winship, M. Grace, Cigarette smoking and diabetic retinopathy. Diabetes 26(1), 46–49 (1977)CrossRef
12.
Zurück zum Zitat I. Muhlhauser, P. Sawicki, M. Berger, Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. Diabetologia 29(8), 500–502 (1986)CrossRef I. Muhlhauser, P. Sawicki, M. Berger, Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. Diabetologia 29(8), 500–502 (1986)CrossRef
13.
Zurück zum Zitat L.A. Kingsley, J.S. Dorman, B.H. Doft, T.J. Orchard, R.E. LaPorte, L.H. Kuller, A.L. Drash, An epidemiologic approach to the study of retinopathy: the Pittsburgh diabetic morbidity and retinopathy studies. Diabetes Res. Clin. Pract. 4(2), 99–109 (1988)CrossRef L.A. Kingsley, J.S. Dorman, B.H. Doft, T.J. Orchard, R.E. LaPorte, L.H. Kuller, A.L. Drash, An epidemiologic approach to the study of retinopathy: the Pittsburgh diabetic morbidity and retinopathy studies. Diabetes Res. Clin. Pract. 4(2), 99–109 (1988)CrossRef
14.
Zurück zum Zitat M.C. Schumacher, K.R. Smith, Diabetes in Utah among adults: interaction between diabetes and other risk factors for microvascular and macrovascular complications. Am. J. Public Health 78(9), 1195–1201 (1988)CrossRef M.C. Schumacher, K.R. Smith, Diabetes in Utah among adults: interaction between diabetes and other risk factors for microvascular and macrovascular complications. Am. J. Public Health 78(9), 1195–1201 (1988)CrossRef
15.
Zurück zum Zitat K.M. West, L.S. Erdreich, J.A. Stober, Absence of a relationship between smoking and diabetic microangiopathy. Diabetes Care 3(2), 250–252 (1980)CrossRef K.M. West, L.S. Erdreich, J.A. Stober, Absence of a relationship between smoking and diabetic microangiopathy. Diabetes Care 3(2), 250–252 (1980)CrossRef
16.
Zurück zum Zitat A.H. Barnett, J.R. Britton, B.A. Leatherdale, Study of possible risk factors for severe retinopathy in non-insulin dependent diabetes. Br. Med. J. 287(6391), 529 (1983)CrossRef A.H. Barnett, J.R. Britton, B.A. Leatherdale, Study of possible risk factors for severe retinopathy in non-insulin dependent diabetes. Br. Med. J. 287(6391), 529 (1983)CrossRef
17.
Zurück zum Zitat L. Yanko, U. Goldbourt, I.C. Michaelson, A. Shapiro, S. Yaari, Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men. Br. J. Ophthalmol. 67(11), 759–765 (1983)CrossRef L. Yanko, U. Goldbourt, I.C. Michaelson, A. Shapiro, S. Yaari, Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men. Br. J. Ophthalmol. 67(11), 759–765 (1983)CrossRef
18.
Zurück zum Zitat S. Telmer, J.S. Christiansen, A.R. Andersen, J. Nerup, T. Deckert, Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med. Scand. 215(1), 63–68 (1984)CrossRef S. Telmer, J.S. Christiansen, A.R. Andersen, J. Nerup, T. Deckert, Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med. Scand. 215(1), 63–68 (1984)CrossRef
19.
Zurück zum Zitat L.I. Rand, A.S. Krolewski, L.M. Aiello, J.H. Warram, R.S. Baker, T. Maki, Multiple factors in the prediction ofrisk of proliferative diabetic retinopathy. N. Engl. J. Med 313(23), 1433–1438 (1985).CrossRef L.I. Rand, A.S. Krolewski, L.M. Aiello, J.H. Warram, R.S. Baker, T. Maki, Multiple factors in the prediction ofrisk of proliferative diabetic retinopathy. N. Engl. J. Med 313(23), 1433–1438 (1985).CrossRef
20.
Zurück zum Zitat D.J. Ballard, L.J. Melton 3rd, M.S. Dwyer, J.C. Trautmann, C.P. Chu, W.M. O’Fallon, P.J. Palumbo, Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Diabetes Care 9(4), 334–342 (1986)CrossRef D.J. Ballard, L.J. Melton 3rd, M.S. Dwyer, J.C. Trautmann, C.P. Chu, W.M. O’Fallon, P.J. Palumbo, Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Diabetes Care 9(4), 334–342 (1986)CrossRef
21.
Zurück zum Zitat S.E. Moss, R. Klein, B.E. Klein, Association of cigarette smoking with diabetic retinopathy. Diabetes Care 14(2), 119–126 (1991)CrossRef S.E. Moss, R. Klein, B.E. Klein, Association of cigarette smoking with diabetic retinopathy. Diabetes Care 14(2), 119–126 (1991)CrossRef
22.
Zurück zum Zitat G. Marshall, S.K. Garg, W.E. Jackson, D.L. Holmes, H.P. Chase, Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology 100(8), 1133–1139 (1993)CrossRef G. Marshall, S.K. Garg, W.E. Jackson, D.L. Holmes, H.P. Chase, Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus. Ophthalmology 100(8), 1133–1139 (1993)CrossRef
23.
Zurück zum Zitat J.M. Sparrow, B.K. McLeod, T.D. Smith, M.K. Birch, A.R. Rosenthal, The prevalence of diabetic retinopathy and maculopathy and their risk factors in the non-insulin-treated diabetic patients of an English town. Eye 7(Pt 1), 158–163 (1993).CrossRef J.M. Sparrow, B.K. McLeod, T.D. Smith, M.K. Birch, A.R. Rosenthal, The prevalence of diabetic retinopathy and maculopathy and their risk factors in the non-insulin-treated diabetic patients of an English town. Eye 7(Pt 1), 158–163 (1993).CrossRef
24.
Zurück zum Zitat M.S. Chen, C.S. Kao, C.J. Chang, T.J. Wu, C.C. Fu, C.J. Chen, T.Y. Tai, Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am. J. Ophthalmol. 114(6), 723–730 (1992)CrossRef M.S. Chen, C.S. Kao, C.J. Chang, T.J. Wu, C.C. Fu, C.J. Chen, T.Y. Tai, Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am. J. Ophthalmol. 114(6), 723–730 (1992)CrossRef
25.
Zurück zum Zitat S.E. Moss, R. Klein, B.E. Klein, Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology 103(9), 1438–1442 (1996)CrossRef S.E. Moss, R. Klein, B.E. Klein, Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology 103(9), 1438–1442 (1996)CrossRef
26.
Zurück zum Zitat Callaghan, B. C., Little, A. A., Feldman, E. L., Hughes, R. A., Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst. Rev. 6, CD007543 (2012). Callaghan, B. C., Little, A. A., Feldman, E. L., Hughes, R. A., Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst. Rev. 6, CD007543 (2012).
27.
Zurück zum Zitat X. Zeng, Y. Zhang, J.S. Kwong, C. Zhang, S. Li, F. Sun, Y. Niu, L. Du, The methodological quality assessmenttools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: asystematic review. J. Evid. Based Med 8(1), 2–10 (2015).CrossRef X. Zeng, Y. Zhang, J.S. Kwong, C. Zhang, S. Li, F. Sun, Y. Niu, L. Du, The methodological quality assessmenttools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: asystematic review. J. Evid. Based Med 8(1), 2–10 (2015).CrossRef
29.
Zurück zum Zitat J.P.Higgins, D.G. Altman, P.C. Gotzsche, P. Juni, D. Moher, A.D. Oxman, J. Savovic, K.F. Schulz, L. Weeks, J.A. Sterne, G. Cochrane Bias Methods; Cochrane Statistical Methods, G., The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343, d5928 (2011).CrossRef J.P.Higgins, D.G. Altman, P.C. Gotzsche, P. Juni, D. Moher, A.D. Oxman, J. Savovic, K.F. Schulz, L. Weeks, J.A. Sterne, G. Cochrane Bias Methods; Cochrane Statistical Methods, G., The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343, d5928 (2011).CrossRef
30.
Zurück zum Zitat D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, D. Rennie, D. Moher, B.J. Becker, T.A. Sipe, S.B. Thacker, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in Epidemiology (MOOSE) group. JAMA 283(15), 2008–2012 (2000)CrossRef D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, D. Rennie, D. Moher, B.J. Becker, T.A. Sipe, S.B. Thacker, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in Epidemiology (MOOSE) group. JAMA 283(15), 2008–2012 (2000)CrossRef
31.
Zurück zum Zitat I. Muhlhauser, R. Bender, U. Bott, V. Jorgens, M. Grusser, W. Wagener, H. Overmann, M. Berger, Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diabet. Med 13(6), 536–543 (1996).CrossRef I. Muhlhauser, R. Bender, U. Bott, V. Jorgens, M. Grusser, W. Wagener, H. Overmann, M. Berger, Cigarette smoking and progression of retinopathy and nephropathy in type 1 diabetes. Diabet. Med 13(6), 536–543 (1996).CrossRef
32.
Zurück zum Zitat B. Karamanos, M. Porta, M. Songini, Z. Metelko, Z. Kerenyi, G. Tamas, R. Rottiers, L.K. Stevens, J.H. Fuller, Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study. Diabetologia 43(3), 348–355 (2000)CrossRef B. Karamanos, M. Porta, M. Songini, Z. Metelko, Z. Kerenyi, G. Tamas, R. Rottiers, L.K. Stevens, J.H. Fuller, Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study. Diabetologia 43(3), 348–355 (2000)CrossRef
33.
Zurück zum Zitat N. Chaturvedi, J.M. Stephenson, J.H. Fuller, The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Diabetes Care 18(6), 785–792 (1995)CrossRef N. Chaturvedi, J.M. Stephenson, J.H. Fuller, The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Diabetes Care 18(6), 785–792 (1995)CrossRef
34.
Zurück zum Zitat Diabetes, C., Complications Trial /Epidemiology of Diabetes, I., Complications Research, G., J.M. Lachin, N.H.White, D.P. Hainsworth, W. Sun, P.A. Cleary, D.M. Nathan, Effect of intensive diabetes therapy on the progressionof diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes 64(2),631–642 (2015). Diabetes, C., Complications Trial /Epidemiology of Diabetes, I., Complications Research, G., J.M. Lachin, N.H.White, D.P. Hainsworth, W. Sun, P.A. Cleary, D.M. Nathan, Effect of intensive diabetes therapy on the progressionof diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC. Diabetes 64(2),631–642 (2015).
35.
Zurück zum Zitat H.P. Hammes, W. Kerner, S. Hofer, O. Kordonouri, K. Raile, R.W. Holl, D.P.-W.S. Group, Diabetic retinopathyin type 1 diabetes-a contemporary analysis of 8784 patients. Diabetologia 54(8), 1977–1984 (2011).CrossRef H.P. Hammes, W. Kerner, S. Hofer, O. Kordonouri, K. Raile, R.W. Holl, D.P.-W.S. Group, Diabetic retinopathyin type 1 diabetes-a contemporary analysis of 8784 patients. Diabetologia 54(8), 1977–1984 (2011).CrossRef
36.
Zurück zum Zitat V.H. Tam, E.P. Lam, B.C. Chu, K.K. Tse, L.M. Fung, Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus. J. Diabetes Complicat 23(3), 185–193 (2009).CrossRef V.H. Tam, E.P. Lam, B.C. Chu, K.K. Tse, L.M. Fung, Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus. J. Diabetes Complicat 23(3), 185–193 (2009).CrossRef
37.
Zurück zum Zitat S.T. Tseng, S.T. Chou, B.H. Low, F.L. Su, Risk factors associated with diabetic retinopathy onset and progression in diabetes patients: a Taiwanese cohort study. Int. J. Clin. Exp. Med. 8(11), 21507–21515 (2015)PubMedPubMedCentral S.T. Tseng, S.T. Chou, B.H. Low, F.L. Su, Risk factors associated with diabetic retinopathy onset and progression in diabetes patients: a Taiwanese cohort study. Int. J. Clin. Exp. Med. 8(11), 21507–21515 (2015)PubMedPubMedCentral
38.
Zurück zum Zitat Z.L. Zhong, S. Chen, Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population. Exp. Diabetes Res 2012, 350852 (2012).PubMedPubMedCentral Z.L. Zhong, S. Chen, Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population. Exp. Diabetes Res 2012, 350852 (2012).PubMedPubMedCentral
39.
Zurück zum Zitat A. Leone, Biochemical markers of cardiovascular damage from tobacco smoke. Curr. Pharm. Des. 11(17), 2199–2208 (2005)CrossRef A. Leone, Biochemical markers of cardiovascular damage from tobacco smoke. Curr. Pharm. Des. 11(17), 2199–2208 (2005)CrossRef
40.
Zurück zum Zitat M. Brownlee, H. Vlassara, A. Cerami, Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Intern. Med. 101(4), 527–537 (1984)CrossRef M. Brownlee, H. Vlassara, A. Cerami, Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Intern. Med. 101(4), 527–537 (1984)CrossRef
41.
Zurück zum Zitat J.L. Wautier, P.J. Guillausseau, Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab. 27(5 Pt 1), 535–542 (2001)PubMed J.L. Wautier, P.J. Guillausseau, Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab. 27(5 Pt 1), 535–542 (2001)PubMed
42.
Zurück zum Zitat Y. Solberg, M. Rosner, M. Belkin, The association between cigarette smoking and ocular diseases. Surv. Ophthalmol. 42(6), 535–547 (1998)CrossRef Y. Solberg, M. Rosner, M. Belkin, The association between cigarette smoking and ocular diseases. Surv. Ophthalmol. 42(6), 535–547 (1998)CrossRef
43.
Zurück zum Zitat Hypertension in Diabetes Study (HDS): II Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J. Hypertens. 11(3), 319–325 (1993). Hypertension in Diabetes Study (HDS): II Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J. Hypertens. 11(3), 319–325 (1993).
Metadaten
Titel
The association of smoking and risk of diabetic retinopathy in patients with type 1 and type 2 diabetes: a meta-analysis
verfasst von
Xiaoling Cai
Yifei Chen
Wenjia Yang
Xueying Gao
Xueyao Han
Linong Ji
Publikationsdatum
20.08.2018
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-018-1697-y

Weitere Artikel der Ausgabe 2/2018

Endocrine 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.